Erectile dysfunction treatment drug launched by Dr Reddy’s Lab

Erectile dysfunction treatment drug launched by Dr Reddy’s Lab

New Delhi: Dr Reddy’s Laboratories today launched Tadalafil tablets, used to treat erectile dysfunction, in the US market.

Erectile dysfunction treatment drug

As stated by Dr Reddy’s Laboratories in a BSE filing Tadalafil tablets are therapeutic equivalent generic version of Adcirca tablets. Shares of Dr Reddy’s are trading 0.01 % lower at Rs 2,616.70 a piece on the BSE sensex.

IMS Health data

Dr Reddy’s Laboratories said, the Adcirca brand and generic had US sales of approximately USD 490 million for the most recent twelve months ending in November 2018.

Leave a Reply

Your email address will not be published. Required fields are marked *

%d bloggers like this: